DavidMMarkovitzMD
Infectious Disease • Ann Arbor, MIProfessor, Internal Medicine, University of Michigan Medical School
Dr. Markovitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 East Medical Center Dr
3rd Floor Taubman Ctr Recp D
Ann Arbor, MI 48109Phone+1 734-647-5899
Education & Training
University of North Carolina HospitalsFellowship, Infectious Disease, 1986 - 1988
University of Rochester Medical CenterFellowship, Infectious Disease, 1984 - 1986- University of Rochester Medical CenterResidency, Internal Medicine, 1981 - 1984
University of Minnesota Medical SchoolClass of 1981
Certifications & Licensure
NY State Medical License 1982 - Present
MI State Medical License 1988 - 2025
FL State Medical License 2014 - 2016
WI State Medical License 1999 - 1999
NC State Medical License 1986 - 1990
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1997
Publications & Presentations
PubMed
- Investigating NanoLuc-EGFR engineered cell lines for real-time monitoring of EGFR protein dynamics in live cells.Ranjit K Mehta, Mingjia Tan, Mohammed K Hassan, Tengda Zhao, David M Markovitz
Biochemical and Biophysical Research Communications. 2024-11-12 - 2 citationsNon-targeted N-glycome profiling reveals multiple layers of organ-specific diversity in mice.Johannes Helm, Stefan Mereiter, Tiago Oliveira, Anna Gattinger, David M Markovitz
Nature Communications. 2024-11-09 - Non-targeted isomer-sensitive N-glycome analysis reveals new layers of organ-specific diversity in mice.Johannes Stadlmann, Johannes Helm, Stefan Mereiter, Tiago Oliveira, Anna Gattinger
Research Square. 2024-04-09
Journal Articles
- Engineering a therapeutic lectin: uncoupling mitogenicity from antiviral activitySwanson, et al., Cell
Press Mentions
Bananas Could Be the Ultimate Defense Against the Flu and All CoronavirusesFebruary 26th, 2025- Banana-Derived Lectin Therapy Shows Promise Against COVID-19 Variants and Future PandemicsFebruary 26th, 2025
- Bananas Could Be the Silver Bullet Against All Human-Infecting CoronavirusesOctober 15th, 2024
- Join now to see all
Grant Support
- Molecularly Engineered Lectins for Intranasal Prophylaxis and Treatment of CoronavirusesUNIVERSITY OF MICHIGAN AT ANN ARBOR2023–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
